Bioclinical center

We are Bioequivalence Center a state-of-the-art facility dedicated to conducting bioequivalence and biowaiver studies for generic drug products. Our highly experienced team leverages cutting-edge technology and equipment to provide the pharmaceutical industry with reliable data to support the development of safe, effective, and affordable generic medicines. Our center features a 40-bed clinic staffed by skilled physicians, nurses, and research coordinators to ensure the highest standards of care for study participants. We have extensive capabilities for conducting bioequivalence studies for a wide range of dosage forms including tablets, capsules....etc. Our core services include: Bioequivalence studies for EDA submissions Full protocol design and conduct per GCP guidelines State-of-the-art LC-MS/MS technology for analyte quantification Data analysis and statistical evaluation by highly qualified biostatisticians On-time delivery of high-quality reports to meet client timelines With our advanced facilities, experienced team, and rigorous standards, we provide pharmaceutical companies with high-quality, compliant data to support the approval of affordable generic products that expand access to vital medicines around the world. Contact us today to learn more about our bioequivalence services!